[Asia Economy Reporter Chunhee Lee] Handok announced on the 18th that it has joined as a Corporate Validator participating in the maintenance and management of network decentralization of MediBloc's blockchain platform 'Panacea'.
MediBloc's Panacea is a blockchain platform optimized for medical information. It collects and manages scattered medical information through blockchain technology to increase its utilization. Panacea Corporate Validators are responsible for key decision-making regarding Panacea's technology and business, as well as operating consensus nodes.
Having joined Panacea as a Corporate Validator since the 13th, Handok plans to continue discussions with MediBloc on building a healthy medical data ecosystem based on blockchain technology. Additionally, they will conduct comprehensive business consultations related to building patient convenience services associated with various products and services provided by Handok.
Kim Young-jin, Chairman of Handok, stated, "As data becomes increasingly important, the need for patient-centered management and systematic maintenance of medical information data is growing," and added, "Through joining as a Corporate Validator, we will start various consultations with MediBloc to build a healthy medical data ecosystem." Go Woo-kyun, CEO of MediBloc, also said, "At a time when the data protocol launch is imminent, the participation of Handok, a leading global healthcare company in Korea, holds great significance," and "We will continue to accelerate the formation of a transparent and healthy medical data ecosystem through the participation of various validators."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.


